Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial
第一作者机构：[1]Fudan Univ, Canc Ctr, Shanghai, Peoples R China[2]Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Li Jian-Wei,Liu Guang-Yu,Yu Ke-Da,et al.Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial[J].CANCER RESEARCH.2015,75:doi:10.1158/1538-7445.SABCS14-P1-12-02.
APA：
Li, Jian-Wei,Liu, Guang-Yu,Yu, Ke-Da,Ji, Ya-Jie,Mo, Miao...&Shao, Zhi-Ming.(2015).Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial.CANCER RESEARCH,75,
MLA：
Li, Jian-Wei,et al."Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial".CANCER RESEARCH 75.(2015)
医学